| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.8M | +71.3% |
| Cost of Revenue | $17.4M | +68.0% |
| Gross Profit | $24.4M | +73.8% |
| R&D Expense | $4.2M | +14.6% |
| SG&A Expense | $7.1M | +38.6% |
| Operating Income | $8.1M | +2217.8% |
| Interest Expense | -$932K | +6.0% |
| Pre-tax Income | $9.0M | +1283.7% |
| Income Tax | $2.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.1M | -4.7% |
| Accounts Receivable | $19.7M | +85.4% |
| Inventory | $10.1M | -14.9% |
| Current Assets | $56.7M | +14.6% |
| Total Assets | $62.2M | +15.7% |
| Current Liabilities | $5.9M | +39.7% |
| Total Liabilities | $6.3M | +30.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$831K | +61.3% |
| Capital Expenditures | $276K | +20.5% |
| Investing Cash Flow | -$276K | -47.6% |
| Financing Cash Flow | $15K | +137.5% |
| Free Cash Flow | -$1.1M | +53.4% |
| +1322.2% |
| Net Income | $6.6M | +1270.5% |
| EPS (Basic) | $0.41 | +1266.7% |
| EPS (Diluted) | $0.41 | +1266.7% |
| Stockholders' Equity |
| $55.8M |
| +14.3% |